Envista Holdings CORP Form 4 insider transactions

Paul A. Keel, CEO and Director of Envista Holdings Corp, reported a transaction involving the withholding of shares for tax obligations.

Envista Holdings Corp. director Wendy Carruthers acquired 9,330 Restricted Stock Units (RSUs) as part of her annual equity grant for services as a director.

Director Christine A. Tsingos acquired 9,330 Restricted Stock Units (RSUs) from Envista Holdings Corp. as an annual equity grant.

Envista Holdings Corp. reports that Director Vivek Jain was granted 9,330 Restricted Stock Units (RSUs) on May 19, 2026, as part of his annual equity compensation.

Envista Holdings Corp. director Kieran Gallahue was granted 9,330 Restricted Stock Units (RSUs) as part of his annual equity compensation.

Director James Andrew Pierce of Envista Holdings Corp. was granted 9,330 Restricted Stock Units (RSUs) on May 19, 2026, as part of his annual director compensation.

Daniel Raskas, a Director at Envista Holdings Corp., acquired 9,330 Restricted Stock Units (RSUs) as an annual equity grant.

Envista Holdings Corp. reports an annual equity grant of Restricted Stock Units to Director R. Scott Huennekens.

Envista Holdings Corp's CFO, Eric D. Hammes, acquired new restricted stock units, performance share units, and stock options, while also having shares withheld for tax obligations.

Envista Holdings' President of Orthodontics, Veronica Acurio, reported the acquisition of restricted stock units, performance share units, and stock options, alongside a disposition for tax withholding.

Envista Holdings Corp's President of Nobel Biocare, Stefan Nilsson, increased his beneficial ownership through new equity grants and options, while also covering tax obligations.

Envista Holdings Corp's SVP of Strategy & Business Development, Mischa Reis, reported the acquisition of restricted stock units, performance share units, and stock options, alongside a disposition of shares for tax withholding.

Envista Holdings Corp's General Counsel, Mark E. Nance, reported significant equity grants including Restricted Stock Units, Performance Share Units, and stock options.

Envista Holdings' Chief Accounting Officer, Faez C. Kaabi, increased beneficial ownership through a routine Restricted Stock Unit vesting and tax withholding transaction.

Envista Holdings Corp CEO Paul A. Keel reported significant equity grants, including Restricted Stock Units, Performance Share Units, and stock options, aligning his interests with long-term shareholder value.

Envista Holdings Corp's President of Diagnostics, Robert Befidi, reported significant equity grants including Restricted Stock Units, Performance Share Units, and stock options.

Envista Holdings Corp's SVP of Strategy & Business Development, Mischa Reis, exercised stock options and subsequently sold 9,675 shares of common stock under a pre-arranged 10b5-1 trading plan.

Envista Holdings Corp's President of Diagnostics, Robert Befidi, acquired 998 notional shares in the company's deferred contribution program at $23.47 per share.

Envista Holdings Corp's SVP of Strategy & Business Development, Mischa Reis, acquired 2,919 notional shares through the company's Executive Deferred Incentive Program.

Envista Holdings CFO Eric D. Hammes reported the acquisition of 1,119 notional shares in the company's deferred compensation stock fund.

Envista Holdings Corp's CEO, Paul A. Keel, acquired 4,091 notional shares of company common stock through a deferred compensation program.

Envista Holdings Corp's General Counsel, Mark E. Nance, increased his beneficial ownership through a company contribution to his deferred compensation plan.

Envista Holdings Corp's Chief Accounting Officer, Faez C. Kaabi, increased his beneficial ownership of notional shares in the company's stock fund through a deferred compensation program.

Veronica Acurio, President of Orthodontics at Envista Holdings Corp, received 998 notional shares through a routine deferred compensation program.

Envista Holdings Corp CEO Paul Keel filed a Form 4 reporting a planned disposition of 54,097 shares on November 1, 2025, to cover tax obligations from RSU vesting.

Envista Holdings Corp's President of Diagnostics, Robert Befidi, disposed of 3,454 common shares to cover tax withholding obligations related to vested restricted stock units.

Envista Holdings Corporation's Chief Financial Officer, Eric D. Hammes, disposed of 7,654 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Envista Holdings Corp's President of Nobel Biocare, Stefan Nilsson, disposed of 804 common shares to cover tax withholding on vested restricted stock units.

Envista Holdings Corp's President of Orthodontics, Veronica Acurio, disposed of 5,422 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Envista Holdings Corporation's SVP of Strategy & Business Development, Mischa Reis, sold 15,000 shares of common stock for $21.6 per share under a pre-arranged 10b5-1 trading plan.